Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Tsm Tong"'
Autor:
Jch Yuen, Jyy Fung, Ifn Hung, W.-K. Seto, MF Yuen, Tsm Tong, Ching-Lung Lai, Noboru Shinkai, Dkh Wong, Yasuhito Tanaka
Publikováno v:
Hepatology. 54:128A-359A
This free journal suppl. contain abstracts of the 62nd Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting 2011
Autor:
MF Yuen, Bcy Wong, Kwok-Leung Cheung, Wai Man Wong, KC Lai, Aoo Chan, CK Chan, Tsm Tong, Vsy Tang, Whc Hu, SK Lam, Hhx Xia
Publikováno v:
Chinese Journal of Digestive Diseases. 4:132-135
OBJECTIVE: To evaluate the accuracy of a rapid assay that wasdeveloped to detect Helicobacter pylori antigen in the stool,using the principle of immunochromatography, in the Chinese population. METHODS: Eligible patients without prior treatment of H.
Autor:
C. K. Chan, S. K. Lam, W. K. Hung, Hhx Xia, B. C. Y. Wong, Wai Man Wong, V. Y. K. Ho, Ming-Leung Szeto, Grace Sau‐Wai Wong, Whc Hu, MF Yuen, Tsm Tong, F. M. Y. Fung, Kam Chuen Lai, A. W. C. Yip
Publikováno v:
Alimentary Pharmacology & Therapeutics. 16:2067-2072
Summary Background : We have previously shown that ranitidine bismuth citrate-based, clarithromycin-containing triple therapy achieves a higher eradication rate than proton pump inhibitor-based regimens in areas with a high prevalence of metronidazol
Autor:
K. F. Li, P. Lau, Tsm Tong, Benjamin C.Y. Wong, Ming-Leung Szeto, Chee-Kin Hui, Sandi Lam, W. M. Wong, W. K. Hung, K. C. Lai, W. H. C. Hu, Man-Fung Yuen, Y. K. Yee, F. M. Y. Fung, A. W. C. Yip
Publikováno v:
Alimentary Pharmacology & Therapeutics. 15:1959-1965
Background: Rabeprazole is a new proton pump inhibitor with more potent acid suppressive and anti-Helicobacter effects. Aim: To compare two different regimens of rabeprazole-based triple therapy vs. 7-day omeprazole-based triple therapy for the eradi
Autor:
Kent Man Chu, Y. K. Yee, Aoo Chan, Qing Gu, C. K. Chan, B. C. Y. Wong, Tsm Tong, F. M. Y. Fung, Wai Man Wong, KC Lai
Publikováno v:
Alimentary pharmacologytherapeutics. 23(3)
Summary Aim To test the efficacy of levofloxacin-based second-line therapy for resistant Helicobacter pylori infection. Methods One hundred and six patients who failed H. pylori eradication were randomized to receive (i) lansoprazole 30 mg, amoxicill
Autor:
A W C Yip, S. K. Lam, Ming-Leung Szeto, F M Y Fung, W H C Hu, W K Hung, MF Yuen, Wai Man Wong, Y K Yee, Kam Chuen Lai, Benjamin C.Y. Wong, Tsm Tong
Background: The use of proton pump inhibitors for the treatment of functional dyspepsia is controversial and the role of Helicobacter pylori infection in functional dyspepsia is uncertain. Aim: To evaluate the efficacy of different doses of lansopraz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca4ad2fc705724942ec8116608c058aa
http://hdl.handle.net/10722/43105
http://hdl.handle.net/10722/43105
Autor:
Mak LY; Department of Medicine, Queen Mary Hospital, Pok Fu Lam, Hong Kong., Tong TSM; Department of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong., Cheung KS; Department of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong., Chen LJ; Department of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong., Lui KL; Department of Medicine, Queen Mary Hospital, Pok Fu Lam, Hong Kong., Lau KS; Department of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong., Leung WK; Department of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong.
Publikováno v:
Clinical and translational gastroenterology [Clin Transl Gastroenterol] 2020 Mar; Vol. 11 (3), pp. e00138.
Autor:
Leung WK; Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong, China., Guo CG; Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong, China., Ko MKL; Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong, China., To EWP; Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong, China., Mak LY; Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong, China., Tong TSM; Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong, China., Chen LJ; Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong, China., But DYK; Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong, China., Wong SY; Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong, China., Liu KSH; Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong, China., Tsui V; Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong, China., Lam FYF; Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong, China., Lui TKL; Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong, China., Cheung KS; Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong, China., Lo SH; Department of Surgery, Queen Mary Hospital, University of Hong Kong, Hong Kong, China., Hung IFN; Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong, China.
Publikováno v:
Gastrointestinal endoscopy [Gastrointest Endosc] 2020 Jan; Vol. 91 (1), pp. 104-112.e5. Date of Electronic Publication: 2019 Jul 02.